Dapagliflozin Propanediol

CHEMBL2103802 Phase 4 Approved Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

503.0 g/mol

LogP

—

Phase

4

The propanediol co-crystal formulation of dapagliflozin used for type 2 diabetes, heart failure, and chronic kidney disease. The co-crystal improves the solid-state properties of the molecule while maintaining the SGLT2-inhibiting activity of the parent compound.

Molecular Weight

503.0000 g/mol

TPSA

141.00 Å²

Therapeutic Areas

Atrial Fibrillation Benign Prostatic Hyperplasia Bladder Cancer Breast Cancer Cardiovascular Disease Chronic Kidney Disease Colorectal Cancer Heart Failure Hypertension Inflammatory Bowel Disease Major Depressive Disorder Non-Alcoholic Fatty Liver Disease Non-Small Cell Lung Cancer Obesity Ovarian Cancer Pancreatic Cancer Prostate Cancer Schizophrenia Stroke Systemic Lupus Erythematosus Thyroid Cancer Type 2 Diabetes

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure

Embed this structure

SMILES

CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1.C[C@H](O)CO.O

InChI

InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1

Molecular Formula

C24H35ClO9

HBD / HBA

7 / 9

Rotatable Bonds

7

Heavy Atoms

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

The propanediol co-crystal formulation of dapagliflozin used for type 2 diabetes, heart failure, and chronic kidney disease. The co-crystal improves the solid-state properties of the molecule while maintaining the SGLT2-inhibiting activity of the parent compound.

Yes, Dapagliflozin Propanediol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2103802. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24906252. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Looking for patient-friendly information?

Dapagliflozin Propanediol on PillFYI

Structure

Quick Data

Formula: C24H35ClO9

External Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.